index - Myopathies inflammatoires & thérapies innovantes ciblées

Dernières publications

Chargement de la page

Chiffres clés

123 Publications avec texte intégral

Open Access

Chargement de la page

Mots clés

Adolescence Anti-interleukin-6 Polymyositis Arthritis Adjudication Biopsy Antisynthétase Anti-synthetase syndrome Middle Aged Humans Anti-drug antibodies Machine learning Dermatomyositis AAV COVID-19 Fabry disease Auto‐antibodies Autoimmune diseases Anti-IgE IgG B-lymphocyte Animals Skeletal muscle Pharmacology Prognosis Multidisciplinarity Immune checkpoint inhibitors Dependovirus/genetics/immunology Adeno-associated virus vector Inflammatory myopathy Muscle Assisted communication devices Interstitial lung disease Inflammation Auto-antibodies Anti-Mi2 Adeno-associated vector Myocarditis Gene therapy Acute Kidney Injury/epidemiology/etiology AAV vector AAV vectors Data integration Antisynthetase Cytokines Systems biology Outcome measures Myositis Immunotherapy Lysosomal storage diseases Anti-agalsidase antibodies Auto-immunité Case reports Autoantibodies Biomarqueurs Cardio-oncology Anticorps anti-agalsidase Bioelectrical impedance analysis Analyses multidimensionnelles AAV humoral immunity Aldosterone Acid-alpha-glucosidase Mass cytometry Anticorps spécifique des myosites Antibodies Interferon Antibody responses Autoimmunity Aldostérone Sphingosine-1-phosphate Aged Anti‐mitochondrial antibodies AAV antibody Agalsidase Antiphospholipid syndrome Antisynthetase syndrome Amyotrophy Biomarkers Adverse drug reactions Myositis and muscle disease Cancer Active Autoantibody DM Inborn errors of metabolism IMNM Inclusion body myositis Male Adult Myopathy B cell homeostasis Adeno-associated virus Biomarker IBM Anti-MDA5 autoantibodies Deep immune profiling Idiopathic inflammatory myopathies Abnormal movement Amyotrophic lateral sclerosis Anémie hémolytique Female